Tetrazine-Derived Near-Infrared Dye as a Facile Reagent for Developing Targeted Photoacoustic Imaging Agents

Samantha Slikboer, Zoya Naperstkow, Nancy Janzen, Amber Faraday, Yohannes Soenjaya, Johann Le Floc’h, Salma Al-Karmi, Rowan Swann, Kevin Wyszatko, Christine E. M. Demore, Stuart Foster, John F. Valliant
Molecular Pharmaceutics2020
A new photoacoustic (PA) dye was developed as a simple-to-use reagent for creating targeted PA imaging agents. The lead molecule was prepared via an efficient two-step synthesis from an inexpensive commercially available starting material. With the dye's innate albumin-binding properties, the resulting tetrazine-derived dye is capable of localizing to tumor and exhibits a biological half-life of a few hours, allowing for an optimized distribution profile. The presence of tetrazine in turn makes it possible to link the albumin-binding optoacoustic signaling agent to a wide range of targeting molecules. To demonstrate the utility and ease of use of the platform, a novel PA probe for imaging calcium accretion was generated using a single-step bioorthogonal coupling reaction where high-resolution PA images of the knee joint in mice were obtained as early as 1 h post injection. Whole-body distribution was subsequently determined by labeling the probe with 99mTc and performing tissue counting following necropsy. These studies, along with tumor imaging and in vitro albumin binding studies, revealed that the core PA contrast agent can be imaged in vivo and can be easily linked to targeting molecules for organ-specific uptake. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.0c00441. Reagents and general procedures; detailed experimental methods for chemical synthesis, radiosynthesis, and in vivo experiments; NMR spectrum; stability studies; and additional PA imaging data (PDF) This article has not yet been cited by other publications.
Share

Request a Quote or Demo

Contact Us